MPO and metabolic dysfunction-associated steatohepatitis: Recent studies have also indicated that ABAH reduces MPO-dependent hepatocyte death in a non-alcoholic steatohepatitis model, decreases MPO activity in a mouse model of acute stroke, and inhibits MPO activity in sputum from pulmonary cystic fibrosis (148–150).